Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China
· Delayed Price · Currency is CNY 4.200
+0.110 (2.69%)
Apr 29, 2026, 3:14 PM CST
SHE:300267 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 8,663 | 7,033 | 5,734 | 6,621 | 7,322 | 9,777 | Upgrade
|
| Market Cap Growth | 57.30% | 22.66% | -13.40% | -9.58% | -25.11% | 12.59% | Upgrade
|
| Enterprise Value | 8,250 | 6,697 | 5,344 | 6,256 | 7,251 | 9,643 | Upgrade
|
| Last Close Price | 4.20 | 3.41 | 2.78 | 3.21 | 3.52 | 4.70 | Upgrade
|
| PE Ratio | - | - | - | - | 159.37 | - | Upgrade
|
| Forward PE | - | 38.54 | 38.54 | 38.54 | 38.54 | 38.54 | Upgrade
|
| PS Ratio | 8.18 | 6.03 | 5.03 | 3.71 | 3.92 | 4.37 | Upgrade
|
| PB Ratio | 2.19 | 1.77 | 1.30 | 1.38 | 1.45 | 2.01 | Upgrade
|
| P/TBV Ratio | 2.34 | 1.89 | 1.41 | 1.49 | 1.58 | 2.22 | Upgrade
|
| P/FCF Ratio | 104.66 | 75.06 | - | - | 68.10 | - | Upgrade
|
| P/OCF Ratio | 34.39 | 27.30 | 34.40 | 44.61 | 26.06 | 105.49 | Upgrade
|
| EV/Sales Ratio | 7.79 | 5.75 | 4.69 | 3.51 | 3.88 | 4.31 | Upgrade
|
| EV/EBITDA Ratio | 42.75 | 35.21 | 52.75 | 386.29 | 45.89 | 234.66 | Upgrade
|
| EV/EBIT Ratio | - | 426.25 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 99.67 | 71.47 | - | - | 67.43 | - | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.15 | 0.12 | 0.07 | 0.08 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 3.72 | 2.84 | 4.75 | 16.27 | 2.43 | 5.41 | Upgrade
|
| Debt / FCF Ratio | 8.66 | 6.28 | - | - | 3.75 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.09 | -0.10 | -0.07 | -0.08 | -0.09 | -0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.98 | -2.10 | -3.05 | -24.65 | -3.01 | -12.40 | Upgrade
|
| Net Debt / FCF Ratio | -4.23 | -4.26 | 10.70 | 4.45 | -4.42 | 1.99 | Upgrade
|
| Asset Turnover | 0.21 | 0.23 | 0.21 | 0.32 | 0.33 | 0.37 | Upgrade
|
| Inventory Turnover | 1.30 | 1.54 | 1.32 | 1.99 | 1.90 | 2.61 | Upgrade
|
| Quick Ratio | 1.39 | 1.49 | 1.45 | 1.56 | 1.53 | 2.10 | Upgrade
|
| Current Ratio | 2.09 | 2.23 | 2.43 | 2.87 | 2.88 | 3.90 | Upgrade
|
| Return on Equity (ROE) | -9.88% | -9.53% | -8.52% | -4.50% | 0.75% | -14.90% | Upgrade
|
| Return on Assets (ROA) | 0.08% | 0.19% | -1.06% | -2.02% | -0.12% | -1.56% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.17% | 0.41% | -2.12% | -4.07% | -0.24% | -3.21% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.20% | 0.40% | -2.00% | -3.80% | -0.20% | -3.10% | Upgrade
|
| Earnings Yield | -4.56% | -5.40% | -6.51% | -2.95% | 0.63% | -8.09% | Upgrade
|
| FCF Yield | 0.96% | 1.33% | -0.50% | -1.36% | 1.47% | -2.63% | Upgrade
|
| Dividend Yield | - | - | - | - | 0.85% | - | Upgrade
|
| Payout Ratio | - | - | - | - | 10.29% | - | Upgrade
|
| Buyback Yield / Dilution | 0.15% | -0.01% | -0.01% | -0.11% | 0.11% | 0.04% | Upgrade
|
| Total Shareholder Return | 0.15% | -0.01% | -0.01% | -0.11% | 0.96% | 0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.